A PROSPECTIVE OPEN LABEL SINGLE CENTRE TRIAL OF RBX2660 (MICROBIOTA SUSPENSION) IN THE MANAGEMENT OF HEPATIC ENCEPHALOPATHY (HE)

Registry ID

RBXHE01

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

GOVERNORS OF THE UNIVERSITY OF ALBERTA

Start date

2019-09-06

Last update

2015-12-24

Conditions

• HEPATIC ENCEPHALOPATHY

Related clinical trials

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)
• MULTICENTER, RANDOMIZED PHASE 2B STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF OCR-002 (ORNITHINE PHENYLACETATE) IN HOSPITALIZED PATIENTS WITH CIRRHOSIS AND ASSOCIATED HYPERAMMONEMIA WITH AN EPISODE OF HEPATIC ENCEPHALOPATHY (STOP-HE STUDY)

View on source registry